Punch Line: “From Blending to Molecule Manufacturing — Scaling India’s Fluorochemical Future”
Company Overview:
Stallion India Fluorochemicals Ltd (commonly “Stallion”) is a Mumbai‑based firm founded by Shazad Sheriar Rustomji, who continues as Chairman & Managing Director. The firm aims to be a trusted supplier of refrigerants and specialty gases in both bulk and cylinder forms. Over two decades, Stallion has built deep expertise in fluorochemical debulking, blending, and distribution. Today it also focuses on custom gas formulations (HFCs, HFOs) to meet industry-specific needs.
Stallion operates four plants: Khalapur (Maharashtra), Ghiloth (Rajasthan), Manesar (Haryana), and Panvel (Maharashtra). Its Ghiloth facility handles debulking and bottling to serve growing demand in North India. The company offers gas products across sectors such as semiconductors, automotive, electronics, pharmaceuticals, fire safety, and HVAC.
Its drive to expand into molecule manufacturing (e.g. R‑32) and specialty gases marks the shift from distributor to integrated gas manufacturer.
Key Financial Highlights
Annual Performance (FY 2024‑25 / TTM):
- Revenue: ₹377 Cr (up ~62% YoY)
- Operating Profit: ~₹48 Cr (EBITDA margin ~13%)
- Net Profit: ₹32 Cr (up ~109% YoY)
- EPS: ₹4.08
- Return on Equity: ~15%
Stallion posted strong top‑line growth. Profit margins improved, aided by cost control and scale. However, negative operating cash flow and high working capital remain challenges.
Quarterly Trends (Latest Data)
| Quarter | Sales (₹ Cr) | Operating Profit (₹ Cr) | Net Profit (₹ Cr) | EPS (₹) | OPM % |
|---|---|---|---|---|---|
| Jun 2024 | 73 | 12 | 8 | 1.37 | 17% |
| Sep 2024 | 68 | 2 | 1 | 0.14 | 3% |
| Dec 2024 | 85 | 14 | 10 | 1.59 | 17% |
| Mar 2025 | 152 | 19 | 13 | 1.67 | 12% |
| Jun 2025 | 110 | 14 | 10 | 1.31 | 13% |
These figures show healthy growth in revenue and profits, though margins fluctuate. Investment in expansion and input cost pressures weigh periodically.
Recent Developments & Corporate Actions
- Trading Window Closure: For Q2 FY26, trading window closed on 27 September 2025
- Land Allotment: Received allotment of land in Bhilwara, Rajasthan for R‑32 plant (29 August 2025)
- MoU Signed: Stallion inked MoU with Rajasthan Govt to set up R‑32 manufacturing (August 2025)
- AGM & Shareholder Disclosures: 23rd AGM held in Sept 2025 with outcomes, scrutinizer’s report, etc.
- ESOP Plan Approved: Board approved ESOP 2025
- Earnings & Investor Updates: Released Q1 FY26 results, earnings call transcripts, and monitoring agency reports
- US Tariff Clarification: Management clarified no material impact from U.S. tariffs
Growth Strategy & Expansion Plans
R‑32 Manufacturing Plant — Bhilwara, Rajasthan
- Stage 1 capacity: 5,000 tons, scalable to 10,000 tons
- Investment: ~₹120 Cr
- Expected commercial production: 2026
- Will support refrigerant blends like R‑410A, R‑404A, R‑454B, R‑513A
HFO & Specialty Gas Facility — Mambattu, Andhra Pradesh
- Focus: HFO blends, semiconductor gases (helium, argon), hydrocarbon handling
- Timeline: Operations expected late 2025 / early 2026
- Advantage: Proximity to southern OEMs & export hubs
Semiconductor & Specialty Gas Hub — Khalapur, Maharashtra
- Infrastructure ready to handle high‑pressure cylinders (300-bar)
- On track to commission by end 2025
- Target customers: semiconductor fabs, specialty gas users
Market Snapshot & Share Price (as of Oct 1, 2025)
- Share Price: ₹266.55
- 52‑Week Range: ₹59.91 – ₹257.85
- Market Cap: ~₹1,937 Cr
- PE / ROE / PB: Not reliably available / reporting lag
The company is still small cap, often volatile. Investors should expect swings tied to execution news.
Risks to Watch
- Negative Cash Flow: Despite profit growth, operating cash flows remain weak.
- Execution Risk: Manufacturing new molecules (R‑32 etc.) is operationally demanding.
- Working Capital Strain: Large receivables and inventory could squeeze liquidity.
- Regulatory & Policy Risks: Global shifts in GWP norms, trade bans, or tariffs may affect business.
- Customer Dependency: OEM tie‑ups and approvals in specialty gas markets take time.
Conclusion
Stallion India Fluorochemicals Ltd is actively transforming from a gas blender & distributor into a vertically integrated fluorochemical and specialty gas company. Its expansion into R‑32 manufacturing, HFOs, and high‑purity gases gives it strong runway for growth.
However, the road ahead is risky. Execution, capital cycle management, and cash flows will make or break its future. For long‑term, high‑conviction investors, Stallion offers an intriguing, early stage play in India’s evolving gas / refrigerant sector.








